Gene · 2201
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Selective RelA Inhibitor Based on DSE-FRET Screening Methods. | Int J Mol Sci | 2020 | 33266352 | PubTator, text mining | PubMed |
| Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly Approach to Proteomic Matrisome Characterization. | Int J Mol Sci | 2020 | 33266304 | PubTator, text mining | PubMed |
| Adaptation of the Romanomermis culicivorax CCA-Adding Enzyme to Miniaturized Armless tRNA Substrates. | Int J Mol Sci | 2020 | 33260740 | PubTator, text mining | PubMed |
| Coding Variants Coupled With Rapid Modeling in Zebrafish Implicate Dynein Genes, dnaaf1 and zmynd10, as Adolescent Idiopathic Scoliosis Candidate Genes. | Front Cell Dev Biol | 2020 | 33251213 | PubTator, text mining | PubMed |
| Development and Validation of Multiclass Chiral Pesticide Residues Analysis Method in Tea by QuEChERS Combined Liquid Chromatography Quadruple-Linear Ion Trap Mass Spectrometry. | J AOAC Int | 2020 | 33241360 | PubTator, text mining | PubMed |
| An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. | Mol Neurodegener | 2020 | 33213497 | PubTator, text mining | PubMed |
| miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1. | Comput Math Methods Med | 2020 | 33204298 | PubTator, text mining | PubMed |
| Marfan syndrome: whole-exome sequencing reveals de novo mutations, second gene and genotype-phenotype correlations in the Chinese population. | Biosci Rep | 2020 | 33200202 | PubTator, text mining | PubMed |
| A case report of congenital myasthenic syndrome caused by a mutation in theCHRNE genein the Iranian population. | Iran J Child Neurol | 2020 | 33193787 | PubTator, text mining | PubMed |
| Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer. | PLoS Genet | 2020 | 33175846 | PubTator, text mining | PubMed |
| Genetic and physiological autonomic nervous system factors involved in failed back surgery syndrome: A review of the literature and report of nine cases treated with pulsed radiofrequency. | Acta Biomed | 2020 | 33170173 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| The Evolution of Angiogenic and Inflamed Tumors: The Renal Cancer Paradigm. | Cancer Cell | 2020 | 33157049 | PubTator, text mining | PubMed |
| Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation. | Cancers (Basel) | 2020 | 33143142 | PubTator, text mining | PubMed |
| Development and validation of an analytical method for the extraction, identification, and quantification of multi-mycotoxins in beer using a modified QuEChERS procedure and UHPLC-MS/MS. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2020 | 33136536 | PubTator, text mining | PubMed |
| Novel Modular Rhodopsins from Green Algae Hold Great Potential for Cellular Optogenetic Modulation Across the Biological Model Systems. | Life (Basel) | 2020 | 33126644 | PubTator, text mining | PubMed |
| Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19. | Front Cell Dev Biol | 2020 | 33123533 | PubTator, text mining | PubMed |
| 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. | BMC Urol | 2020 | 33121461 | PubTator, text mining | PubMed |
| Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling. | Stem Cell Res Ther | 2020 | 33115513 | PubTator, text mining | PubMed |
| Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach. | PLoS One | 2020 | 33104727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2201/papers?page=40